Induction of cell death by doxorubicin in multicellular spheroids as studied by confocal laser scanning microscopy

Anticancer Research

Volumn 16, Issue 2, 1996, Pages 573-580

  Wartenberg, Maria ^a,b   Acker, Helmut ^a  

^a MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Cancer; CLSM; Doxorubicin; Lethal staining; Multicellular spheroids

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; DOXORUBICIN;

ARTICLE; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; CONFOCAL LASER MICROSCOPY; CYTOTOXICITY; DRUG DISTRIBUTION; FLUORESCENCE; HUMAN; HUMAN CELL; MALE; MULTICELLULAR SPHEROID; PRIORITY JOURNAL;

ANTIBIOTICS, ANTINEOPLASTIC; CELL DEATH; DOXORUBICIN; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MALE; MICROSCOPY, CONFOCAL; NECROSIS; PROSTATIC NEOPLASMS; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 0029982407     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Sutherland RM, McCredie JA and Inch WR: Growth of multicell spheroids in tissue culture as a model of nodular carcinomas. J Nat Cancer Inst 46: 113-120, 1971.
2. Carlsson J and Yuhas JM: Liquid-overlay culture of cellular spheroids. Rec Res Cancer Res 95: 1-23, 1984.
3. Carlsson J and Nederman T: Tumor spheroid technology in cancer therapy research. Eur J Cancer Clin Oncol 25: 1127-1133, 1989.
4. Durand RE:. Multicell spheroids as a model for cell kinetic studies. Cell Tissue Kinet 23: 141-159, 1990.
5. Carlsson J, Nilsson K, Westermark B, Ponten J, Sundstrom C, Larsson E, Bergh J, Pahlman S, Busch C and Collins VP: Formation and growth of multicellular spheroids of human origin. Int J Cancer 31: 523-533, 1983.
6. Freyer JP: Role of necrosis in regulating the growth saturation of multicellular spheroids. Cancer Res 48: 2432-2439, 1988.
7. Sutherland RM: Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240: 177-184, 1988.
8. Nederman T and Carlsson J: Penetration and binding of vinblastine and 5-fluorouracil in cellular spheroids. Cancer Chemother Pharmacol 13: 131-135, 1984.
9. Durand RE: Slow penetration of anthracyclins into spheroids and tumors: a therapeutic advantage? Cancer Chemother Pharmacol 26: 198, 1990.
10. Kerr DJ and Kaye SB: Aspects of cytotoxic drug penetration, with particular reference to anthracyclines. Cancer Chemother Pharmacol 14: 96, 1987.
11. Arcamone F: Doxorubicin. In: Anticancer Antibiotics. New York: Academic Press. 1981.
12. Durand RE and Olive PL: Flow cytometry studies of intracellular adriamycin in single cells in vitro. Cancer Res 41: 3489-3494, 1981.
13. Durand RE: Chemosensitivity testing in V 79 spheroids: drug delivery and cellular microenvironment. J Natl Cancer Inst 77: 247-252, 1986.
14. Shotton DM: Confocal scanning optical microscopy and its applications for biological specimens. J Cell Sci 94: 175-206, 1989.
15. Wartenberg M and Acker H: Quantitative recording of vitality patterns in living multicellular spheroids by confocal microscopy. Micron (in press) 1995.
16. Gassmann M, Wartenberg M, McClanahan T, Fandrey J, Bichet S, Kreuter R, Acker H and Bauer C: Differentiating embryonic stem cells as an in vitro model of early erythropoiesis. Toxicology in Vitro (in press), 1995.
17. Olive PL and Durand RE: Drug and radiation resistance in spheroids: cell contact and kinetics. Cancer Metast Rev 13: 121-138, 1994.
18. Stone KR, Mickey DD, Wunderli H, Mickey GH and Paulson DF: Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer 21: 274-281, 1978.
19. Mickey DD, Stone KR, Wunderli H, Mickey GH, Vollmer RT and Paulson DP: Heterotransplantation of a human prostatic adenocarcinoma cell line in nude mice. Cancer Res 37: 4049-4058, 1977.
20. Carlsson J and Nederman T: A method to measure the radio- and chemosensitivity of human spheroids. Adv Exp Med Biol 159: 399-417, 1983.
21. Gaugain B, Barbet J, Oberlin R, Roques BP and LePecq J-B: DNA bifunctional interactions. 1.Synthesis and conformational properties of an Ethidium homodimer and of an Acredine Ethidium heterodimer. Biochemistry 17: 5071-5078, 1978.
22. Stewart WW: Lucifer dyes - highly fluorescent dyes for biological tracing. Nature 292: 17-21, 1981.
23. Liminga G, Nygren P and Larsson R: Microfluorometric evaluation of calcein acetoxymethyl ester as a probe for P-glycoprotein-mediated resistance: effects of Cyclosporin A and ist nonimmunosuppressive analogue SDZ PSC 833. Exp Cell Res 212: 291-296, 1994.
24. Kobayashi H, Man S, Graham CH, Kapitain SJ, Taicher BA and Kerbel RS: Aquired multicellular mediated resistance to alkylating agents in cancer. Proc Natl Acad Sci USA 90: 3294-3298, 1993.
25. Erlichman C and Vidgen D: Cytotoxicity of doxorubicin in MGH-U1 cells grown as monolayer cultures, spheroids and xenografts in immune-deprived mice. Cancer Res 44: 5469-5475, 1984.
26. Kwok TT and Twentyman PR: The relationship between tumour geometry and the response of tumour cells to cytotoxic drugs- an in vitro study using EMT6 multicellular spheroids. Int J Cancer 35: 675-682, 1985.
27. Erlanson M, Daniel-Szolgay E and Carlsson J: Relations between the penetration, binding and average concentration of cytostatic drugs in human tumor spheroids. Cancer Chemother Pharmacol 29: 343-353, 1992.
28. Inoue S, Ohnuma T, Takaoka K, Suzuki Y, Kaneko M, Safirstein R and Holland JF: Effects of doxorubicin and cisplatin on multicellular tumor spheroids from human lung cancer. Cancer Drug Del 4: 213-224, 1987.
29. West CML and Stratford IJ: A comparison of doxorubicin and m-AMSA. II. Studies with V79 and human tumour multicellular spheroids. Cancer Chemother Pharmacol 20: 109-114, 1987.
30. Lange de JHM, Schipper NW, Schuurhuis GJ, Kateten TK, van Heijningen ThHM, Pinedo HM, Lankelma J and Baak JBA: Quantification by laser scann microscopy of intracellular doxorubicin distribution. Cytometry 13: 571-576, 1992.